---
title: Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does
  Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation
  - A Single Center Experience
date: '2023-09-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37659695/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=12iSD5QubOnfg0fkR8dCcveVdPAdI9QKdI-uy_x1YlQTYHygaQ&fc=20221007230549&ff=20230903180416&v=2.17.9.post6+86293ac
source: (Hematopoietic Cell Transplantation) AND (Cryopreserved-Grafts)
description: 'CONCLUSION: There was no demonstrable difference in the risk of chronic
  GHVD. Although longer-term follow-up is needed, these data provide preliminary reassurance
  that in the event of another pandemic or should the logistical need arise in individual
  patients, cryopreservation of PBSC products constitutes a reasonably safe ...'
disable_comments: true
---
CONCLUSION: There was no demonstrable difference in the risk of chronic GHVD. Although longer-term follow-up is needed, these data provide preliminary reassurance that in the event of another pandemic or should the logistical need arise in individual patients, cryopreservation of PBSC products constitutes a reasonably safe ...